Post-thrombotic syndrome (PTS) is a complication of deep vein thrombosis (DVT). Residual
vein thrombus (RVT) on Doppler Ultrasound can be associated with PTS. Limited data are …

Introduction Despite treatment of acute deep vein thrombosis (DVT) with low molecular
weight heparin and warfarin, up to 50% of patients develop post-thrombotic syndrome (PTS) …

Introduction Post-thrombotic syndrome (PTS) is a chronic complication of deep vein
thrombosis (DVT) that affects 20% to 50% of DVT patients. Standard DVT treatment included …

Abstract Objective Direct oral anticoagulants (DOACs) have been recommended for the
treatment of deep vein thrombosis (DVT). However, the benefits are uncertain for the …

Postthrombotic syndrome (PTS) is a frequent complication of venous thromboembolism
(VTE). Using MarketScan claims data from January 2012 to June 2015, we identified adults …

Post-thrombotic syndrome (PTS) is a common complication of deepvein thrombosis (DVT).
Poor quality treatment with vitamin K antagonists (VKA) is a risk factor for PTS. We …

Background The effectiveness of rivaroxaban to reduce post-thrombotic syndrome in
patients with venous thromboembolism is largely unknown. We compared rates of post …

The incidence of post-thrombotic syndrome (PTS) in patients with deep vein thrombosis
(DVT) treated with direct oral anticoagulants (DOACs) remains a matter of debate. Hence …

Post-thrombotic syndrome (PTS) is a common complication of deep venous thrombosis
(DVT) of the iliofemoral venous system leading to significant morbidity and high health care …

Introduction Post-thrombotic syndrome (PTS) is a burdensome long-term complication of
deep vein thrombosis (DVT). Recent studies have suggested that rivaroxaban may reduce …